Roche is putting new emphasis on its diabetes business by drawing a new line on its org chart, straight from diabetes chief Burkhard Piper to CEO presumptive Severin Schwan. Piper will report directly to Schwan, along with the heads of Roche's pharma and diagnostics divisions. It's evidence of a new commitment to the diabetes business--understandable, considering the number of patients is expected to skyrocket in coming years. Report